Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

dc.creatorCachay, Edward R.
dc.creatorMena, Alvaro
dc.creatorMorano, Luis
dc.creatorBenitez, Laura
dc.creatorMaida, Ivana
dc.creatorMendoza, Carmen de
dc.creatorHill, L.
dc.creatorTorriani, F
dc.creatorSoriano, Vicente (1)
dc.creatorMathews, Wm. C.
dc.date.accessioned2022-03-09T12:35:42Z
dc.date.accessioned2023-03-07T19:35:16Z
dc.date.available2022-03-09T12:35:42Z
dc.date.available2023-03-07T19:35:16Z
dc.date.created2022-03-09T12:35:42Z
dc.identifier23259574
dc.identifierhttps://reunir.unir.net/handle/123456789/12592
dc.identifierhttps://doi.org/10.1177/23259582211024771
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5906883
dc.description.abstractFifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary HIV-coinfection model of care integrating sub-specialty services in 3 countries. Of those treated, 91% (95% confidence interval, 80.1 to 95.9) achieved sustained viral response, and only one person died during treatment. Our study provides evidence that HIV providers achieve excellent outcomes when treating patients with histories of decompensated liver disease, with characteristics similar to those studied using a multidisciplinary HIV-centered approach. © The Author(s) 2021.
dc.languageeng
dc.publisherSAGE Publications Inc.
dc.relation;vol. 20
dc.rightsopenAccess
dc.subjectDAA
dc.subjectHCV
dc.subjectHIV
dc.subjectliver decompensation
dc.subjectmultidisciplinary
dc.subjectScopus
dc.subjectEmerging
dc.titleHepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
dc.typearticle


Este ítem pertenece a la siguiente institución